American Society for Preventive Cardiology (ASPC) Has Launched Its Novel Mobile App: PCSK9i Access and It’s Now Available for Download
Google Play: https://play.google.com/store/apps/details?id=com.aspc.conf4cvaob
This innovative tool simplifies the process for clinicians and their office staff to enable patients to gain access to these exceptional medications. The app includes a simple-10-step approach, single page prior authorization and appeal letters published by the ASPC, the
"We all know that PCSK9is have been denied to our patients in an unprecedented manner. I am so proud to announce that ASPC has a solution to this problem by utilizing the information found in the new ASPC Mobile app (PCSK9i Access)," said
For over two years, the ASPC, with the help of many other organizations, has been working diligently to break the barriers to gain access to PCSK9 Inhibitors. Previous publications and recommendations have all culminated in the launching of the PCSK9i Access app, the comprehensive tool every clinician and their supporting staff needs to gain access to these life-saving drugs for their patients.
About the
View original content with multimedia:http://www.prnewswire.com/news-releases/american-society-for-preventive-cardiology-aspc-has-launched-its-novel-mobile-app-pcsk9i-access-and-its-now-available-for-download-300622563.html
SOURCE
CBD Oil: A Game-changer for Pet Medicine
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News